Skip to main content
. Author manuscript; available in PMC: 2023 Apr 1.
Published in final edited form as: Exp Neurol. 2021 Dec 28;350:113963. doi: 10.1016/j.expneurol.2021.113963

Figure 4 – The beneficial effects of ketamine are retained in mbTBI mice.

Figure 4 –

Performance in the forced swim test, a, was evaluated on day 28 post ABS exposure. Ketamine 10 mg/kg reduced immobility scores of mbTBI mice relative to their saline treated controls (p<0.05). On Day 74 post ABS exposure, mbTBI was associated with a marked reduction in sucrose consumption b and increase in water intake c relative to Sham controls (p<0.05). This deficit was reversed following ketamine 10mg/kg administration (p<0.05).